CLAR1, a novel gene that exhibits enhanced expression in advanced human prostate cancer

Clinical Cancer Research

Volumn 5, Issue 6, 1999, Pages 1595-1602

  Rondinelli, Rachel H ^a   Tricoli, James V ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 19Q; CONTROLLED STUDY; GENE ISOLATION; GENE LOCATION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; BLOTTING, NORTHERN; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 19; CLONING, MOLECULAR; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; ORGAN SPECIFICITY; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0033012726     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. 1996. Cancer statistics. CA Cancer J. Clin., 46: 5-27, 1996.
2. Epstein, J. I., Walsh, P. C., Carmichael, M., and Brendler, C. B. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1C) prostate cancer. J. Am. Med. Assoc., 271: 368-374, 1994.
3. Kramer, S. A., Spahr, J., Brendler, C. B., Glenn, J. F., and Paulson, D. F. Experience with Gleason's histopathologic grading in prostatic cancer. J. Urol., 124: 223-225, 1980.
4. Bussemakers, M. J. G., van de Ven, W. J. M., Debruyne, F. M. J., and Schalken, J. A. Identification of high mobility group protein 1(Y) as a potential progression marker for prostate cancer by differential hybridization analysis. Cancer Res., 51: 606-611, 1991.
5. Bussemakers, M. J. G., van Moorselaar, R. J. A., Giroldi, L. A., Ichikawa, T., Isaacs, J. T., Takeichi, M., Debruyne, F. M. J., and Schalken, J. A. Decreased expression of e-cadherin in the progression of rat prostate cancer. Cancer Res., 52: 2916-2922, 1992.
6. Bussemakers, M. J. G., Verhaegh, G. W. C. T., van Bokhoven, A., Debruyne, F. M. J., and Schalken, J. A. Differential expression of vimentin in rat prostatic tumors. Biochem. Biophys. Res. Commun., 182: 1254-1259, 1992.
7. Foster, C. S., McLoughlin, J., Bashir, I., and Abel, P. D. Markers of the metastatic phenotype in prostate cancer. Hum. Pathol., 23: 381-394, 1992.
8. Umbas, R., Schalken, J. A., Aalders, T. W., Carter, B. S., Karthaus, H. F. M., Schaafsma, H. E., Debruyne, F. M. J., and Isaacs, W. B. Expression of the cellular adhesion molecule e-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res., 52: 5104-5109, 1992.
9. Morton, R. A., Ewing, C. M., Nagafuchi, A., Tsukita, S., and Isaacs, W. B. Reduction of e-cadherin levels and deletion of the α-catenin gene in human prostate cancer cell lines. Cancer Res., 53: 3585-3590, 1993.
10. Umbas, R., Isaacs, W. B., Bringuier, P. P., Schaafsma, H. E., Karthaus, H. F. M., Oosterhof, G. O. N., Debruyne, F. M. J., and Schalken, J. A. Decreased e-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res., 54: 3929-3933, 1994.
11. Richmond, P. J. M., Karayiannakis, A. J., Nagafuchi, A., Kaisary, A. V., and Pignatelli, M. Aberrant e-cadherin and α-catenin expression in prostate cancer: correlation with patient survival. Cancer Res., 57: 3189-3193, 1997.
12. Dong, J-T., Lamb, P. W., Rinker-Schaeffer, C. W., Vukanovic, J., Ichikawa, T., Isaacs, J. T., and Barrett, J. C. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science (Washington DC), 268: 884-886, 1995.
13. Sokolav, B. P., and Prockop, D. J. A rapid and simple PCR-based method for isolation of cDNAs from differentially expressed genes. Nucleic Acids Res., 22: 4009-4015, 1994.
14. Liang, P., and Pardee, A. B. Differential display of eukaryotic mRNA by means of the polymerase chain reaction. Science (Washington DC), 257: 967-971, 1992.
15. Tricoli, J. V., Rall, L. B., Karakousis, C. P., Herrera, L., Petrelli, N. J., Bell, G. I., and Shows, T. B. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res., 46: 6169-6173, 1986.
16. Tricoli, J. V., Gumerlock, P. H., Yao, J. L., Chi, S-G., D'Souza, S. A., Nestok, B. R., deVere White, R. W., and The Cooperative Prostate Network, National Cancer Institute. Retinoblastoma gene alterations in human prostate adenocarcinoma. Genes Chromosomes Cancer, 15: 108-114, 1996.
17. Fan, Y-S., Davis, L. M., and Shows, T. B. Mapping small DNA sequences by fluorescence in situ hybridization directly on banded metaphase chromosomes. Proc. Natl. Acad. Sci. USA, 87: 6223-6227, 1990.
18. Bell, D. W., Taguchi, T., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., Gilks, C. B., Zweidler-McKay, P., Grimes, H. L., Tsichlis, P. N., and Testa, J. R. Chromosomal localization of a gene, GFI1, encoding a novel zinc finger protein reveals a new syntenic region between man and rodents. Cytogenet. Cell Genet., 70: 263-267, 1995.
19. Kaighn, M. E., Reddel, R. R., Lechner, J. F., Peehl, D. M., Camalier, R. F., Brash, D. E., Saffiotti, U., and Harris, C. C. Transformation of human neonatal prostate epithelial cells by strontium phosphate transfection with a plasmid containing SV40 early region genes. Cancer Res., 49: 3050-3056, 1989.
20. Peterson, R. O. Urologic Pathology, p. 578. Philadelphia: J. B. Lippincott Co., 1992.
21. Cross, S. H., Charlton, J. A., Nan, X., and Bird, A. P. Purification of CpG islands using a methylated DNA binding column. Nat. Genet., 6: 236-244, 1994.
22. Sutherland, G. R., Baker, E., Hyland, V. J., Callen, D. F., Close, J. A., Tregear, G. W., Evans, B. A., and Richards, R. I. Human prostate-specific antigen (APS) is a member of the glandular kallikrein gene family at 19q13. Cytogenet. Cell. Genet., 48: 205-207, 1988.
23. Ropers, H-H., and Pericak-Vance, M. A. Report of the committee on the genetic constitution of chromosome 19. Cytogenet. Cell. Genet., 55: 218-228, 1990.
24. Schonk, D., van Dijk, P., Riegman, P., Trapman, J., Holm, C., Willcocks, T. C., Sillekens, P., van Venrooij, W., Wimmer, E. M., Geurts van Kessel, A., Ropers, H-H., and Wieringa, B. Assignment of seven genes to distinct intervals on the midportion of human chromosome 19q surrounding the myotonic dystrophy gene region. Cytogenet. Cell. Genet., 54: 15-19, 1990.
25. Riegman, P. H. J., Vlietstra, R. J., Suurmeijer, L., Cleutjens, C. B. J. M., and Trapman, J. Characterization of the human kallikrein locus. Genomics, 14: 6-11, 1992.
26. Feng, S., Chen, J. K., Yu, H., Simon, J. A., and Schreiber, S. L. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science (Washington DC), 266: 1241-1247, 1994.
27. Yu, H., Chen, J. K., Feng, S., Dalgarno, D. C., Brauer, A. W., and Schreiber, S. L. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell, 76: 933-945, 1994.
28. Cohen, G. B., Ren, R., and Baltimore, D. Modular binding domains in signal transduction proteins. Cell, 80: 237-248, 1995.
29. Mayer, B. J., and Baltimore, D. Signalling through SH2 and SH3 domains. Trends Cell Biol., 3: 8-13, 1993.
30. Pelech, S. L., and Sanghera, J. S. Mitogen-activated protein kinases: versatile transducers for cell signaling. Trends Biochem. Sci., 17: 233-238, 1992.